首页> 外文期刊>The Canadian journal of cardiology >Outcomes of Patients With ST-Elevation Myocardial Infarction Receiving and Not Receiving Reperfusion Therapy: The Importance of Examining All Patients
【24h】

Outcomes of Patients With ST-Elevation Myocardial Infarction Receiving and Not Receiving Reperfusion Therapy: The Importance of Examining All Patients

机译:ST抬高型心肌梗死患者接受和不接受再灌注治疗的结果:检查所有患者的重要性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Hospitals treating patients with ST-elevation myocardial infarction (STEMI) may show good results with reperfusion treatment (fibrinolysis or primary percutaneous coronary intervention [PPCI]), but a comprehensive evaluation should factor in outcomes of patients with STEMI who do not receive reperfusion. We compared outcomes of patients receiving and not receiving reperfusion within a complete system of STEMI care by hospital type: PPCI centres, fibrinolysis centres, centres that only transfer for PPCI, and centres providing a mix of fibrinolysis and PPCI transfer.
机译:背景:治疗ST抬高型心肌梗死(STEMI)的医院通过再灌注治疗(纤维蛋白溶解或原发性经皮冠状动脉介入治疗[PPCI])可能会显示出良好的效果,但综合评估应考虑未接受再灌注的STEMI患者的预后。我们按医院类型比较了在完整的STEMI护理系统中接受和不接受再灌注的患者的结局:PPCI中心,纤溶中心,仅转运PPCI的中心以及提供纤溶和PPCI混合的中心。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号